American Century Companies’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,565
Closed -$36.9K 2828
2025
Q2
$36.9K Buy
18,565
+1,345
+8% +$2.46K ﹤0.01% 2836
2025
Q1
$25K Buy
17,220
+30
+0.2% +$55 ﹤0.01% 2880
2024
Q4
$35.6K Buy
17,190
+14
+0.1% +$26 ﹤0.01% 2878
2024
Q3
$30.2K Buy
17,176
+18
+0.1% +$46 ﹤0.01% 2873
2024
Q2
$248K Buy
17,158
+1
+0% +$14 ﹤0.01% 2689
2024
Q1
$285K Buy
17,157
+4,864
+40% +$77.8K ﹤0.01% 2662
2023
Q4
$197K Buy
+12,293
New +$163K ﹤0.01% 2698

American Century Companies's HLVX Position: Q3 2025 in Review

American Century Companies sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 18,565 shares — an estimated $36.9K sold.

American Century Companies first reported a position in HLVX in Q4 2023 and held it in 7 quarters. The position peaked at $285K in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • American Century Companies reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • American Century Companies sold 18,565 HilleVax shares in Q3 2025, an estimated $36.9K.
  • American Century Companies first reported a position in HilleVax in Q4 2023 and held it in 7 quarters.
  • American Century Companies's HilleVax position peaked at $285K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.